Introduction
============

The umbilical cord normally serves as the conduit for two umbilical arteries and one umbilical vein. Single umbilical artery (SUA) is characterized by absence of one of the umbilical arteries and its incidence occurs in 0.5% to 5% of pregnancies \[[@B1][@B2][@B3]\]. Till now, the mechanism of its development remains uncertain. There are three widely accepted explanations concerning the pathogenesis of an absent umbilical artery: (1) primary agenesis of one umbilical artery; (2) secondary atrophy or atresia of a previously normal developed umbilical artery; and (3) persistence of the original allantoic artery of the body stalk. Embryological considerations, as well as the detection of occluded remnants of a second umbilical artery in some SUA fetuses, suggest that the second theory is the most likely explanation \[[@B4][@B5][@B6]\].

Fetuses with a SUA are considered at increased risk of chromosomal and structural abnormalities \[[@B1][@B7][@B8][@B9][@B10]\]. Therefore, when SUA is diagnosed at the time of the mid-trimester scan, targeted ultrasound is warranted to rule out underlying pathologic conditions. SUA is defined as an isolated SUA (iSUA), if it occurs with no congenital abnormality in fetal chromosomes or structure \[[@B11]\]; In approximately 65% to 80% of SUAs, it appears to be iSUAs. In pregnancies with an iSUA, variable outcomes of aneuploidy, small for gestational age (SGA), preterm birth, pregnancy-induced hypertension (PIH), neonatal intensive care unit (NICU) admission, and perinatal mortality have been reported when compared with those fetuses and neonates with three vessel cords (TVC) \[[@B11][@B12][@B13][@B14][@B15][@B16][@B17][@B18][@B19][@B20][@B21]\]. However, a controversy exists concerning whether iSUA is associated with adverse perinatal outcomes, with other studies presenting different views.

We carried out a comprehensive systematic review of the literature to evaluate the association of fetuses with prenatally diagnosed iSUA and perinatal outcomes.

Materials and methods
=====================

This systematic review was protocol driven using widely recommended methods for reviews and evaluation of causal associations. The review was carried out and has been reported according to the PRISMA (Preferred Reporting Items for Systematic review and Meta-Analysis) and MOOSE (Meta-analysis of Observational Studies in Epidemiology) guidelines.

1. Data sources and search strategy
-----------------------------------

We searched Medline, Embase, the Cochrane Library, and KoreaMed, from inception until January 2016 for relevant published articles. "Single umbilical artery," "two vessel cord," "two umbilical vessels," "SUA," "pregnancy outcome," and "perinatal outcome" were entered as MeSH (Medical Subject Heading) terms and as keywords. The terms were then connected through Boolean operators and the result was limited to studies reporting only on human subjects and clinical trials. We had no limitations on whether clinical trial was controlled or randomized, on language, or age group. We adapted the Medline search strategy for use in other databases.

2. Eligibility criteria
-----------------------

Randomized controlled trials, cohort studies and case--control studies were considered eligible if they described iSUA identified by ultrasound before an average gestational age of 24 completed weeks and perinatal outcomes. Studies were excluded if SUA was first diagnosed at birth or if the study was only on twin pregnancies. And we excluded studies with fifty or fewer cases, because of unreliability.

3. Study selection
------------------

We selected studies for inclusion in a two-stage process. First, two independent reviewers (A and B) screened the titles and abstracts to identify eligible studies; Second, this screening was followed by retrieval and assessment of the full texts of the relevant citations. When the same dataset was reported multiple times, we extracted data from the most recent study with the largest sample size for relevant outcomes. Any disagreements were resolved after discussion with a third reviewer (C).

4. Data extraction
------------------

Data were extracted in duplicate (A and B) with predesigned data collection form. Study characteristics that were summarized on the form included: first author, year of publication, data collection period, country of investigation and number of cases of iSUA and control groups. Quantitative data on the outcome variables included incidence of SGA, PIH, preterm labor, NICU admission and perinatal mortality. Dichotomous data were extracted as 2×2 tables of the association between the iSUA and the perinatal outcome.

5. Study quality assessment
---------------------------

We used the Newcastle-Ottawa Scale, which assigns points depending on the quality of patient selection (maximum 4 stars), comparability of the cohort (maximum 2 stars), and outcome assessment (maximum 3 stars) to assess the methodological quality of the included studies. Two independent reviewers (A and B) undertook quality assessment and allocated stars. Studies that scored four stars for selection, two stars for comparability, and three stars for ascertainment of the outcome were regarded to have a low risk of bias. Studies with two or three stars for selection, one for comparability, and two for outcome ascertainment were deemed to have a medium risk of bias. Any study with a score of one for selection or outcome ascertainment, or zero for any of the three domains, was deemed to have a high risk of bias.

6. Data synthesis and statistical analysis
------------------------------------------

Measures of effect used for dichotomous data are the odds ratio (OR). Methods used in this meta-analysis are specific to meta-analysis and include heterogeneity analysis, sensitivity analysis, and evaluation of publication bias. All methods used should allow for the weighting of studies. The concept of weighting reflects the value of the evidence of any particular study. Usually, studies are weighted according to the inverse of their variance. We tested the heterogeneity of results across the studies using the I^2^ test. If statistical heterogeneity was small (I^2^\<50%) a Mantel-Haenszel fixed-effects model was used. For studies with moderate statistical heterogeneity (I^2^\>50%), we used a Mantel-Haenszel random-effects model. We created funnel plots by plotting the natural logarithm of the ORs against the inverse of the standard error to assess publication and related bias. We statistically checked for the asymmetry of the funnel plot. We identified 11 studies and use software RevMan ver. 5.0 (The Cochrane Collaboration, Oxford, UK) to estimate effects size.

Results
=======

1. Study characteristics and quality assessment
-----------------------------------------------

An initial search of 4,706 citations identified from the four databases. Of the 109 eligible articles, we selected 57 studies for detailed assessment. Of these, 46 studies did not meet the inclusion criteria, leaving 11 studies for inclusion in the systematic review. The selection process of the studies and reasons for exclusion are shown in [Fig. 1](#F1){ref-type="fig"}. [Table 1](#T1){ref-type="table"} shows the characteristics of the 11 included studies \[[@B11][@B12][@B13][@B14][@B15][@B16][@B17][@B18][@B19][@B20][@B21]\]. The studies comprised 3 case-control studies and 8 cohort studies. These studies reported iSUA cases between 68 and 392, resulting in a total number of cases with an iSUA of 1,731. Quality assessment by the Newcastle-Ottawa Scale showed that all of the included studies had medium risk of bias. One of the 11 studies had low risk of bias for study selection, 10 had medium risk of bias. For comparability of the cohorts, all of the studies had low risk of bias. The risk of bias for outcome assessment was low in 6 studies, medium in 5 studies.

2. SGA
------

Eleven studies (8 cohort studies and 3 case-control studies) totaling 1,731 fetuses with iSUA reported on the association between SGA and iSUA. All studies had an OR point estimate greater than 1.0 and OR was 2.75, implying that the incidence of SGA in fetuses with iSUA was significantly higher than in fetuses with TVC, and iSUA increased the risk of SGA. Heterogeneity was significant (I^2^=71%) overall ([Fig. 2](#F2){ref-type="fig"}) \[[@B11][@B12][@B13][@B14][@B15][@B16][@B17][@B18][@B19][@B20][@B21]\].

3. Preterm birth
----------------

For preterm birth, 5 studies totaling 127,742 pregnancies examined the association between iSUA and preterm birth. However, these studies did not differentiate between medically indicated and spontaneous preterm deliveries. No heterogeneity was found (chi^2^=3.09, *P*=0.66, I^2^=3%), we chose fixed-effects model to do the meta-analysis. 4 studies had an OR point estimate greater than 1.0. The overall association was OR 2.10 (95% CI, 1.72 to 2.57; *P*\<0.00001). These results suggest that the incidence of preterm birth in fetuses with iSUA was significantly higher than in fetuses with TVC, and iSUA increased the risk of any preterm birth ([Fig. 3](#F3){ref-type="fig"}) \[[@B11][@B13][@B17][@B18][@B20]\]

4. PIH
------

The association between PIH and iSUA were assessed in 7 studies. Significant heterogeneity was found (chi^2^=17.18, *P*=0.009, I^2^=65%) ([Fig. 4](#F4){ref-type="fig"}) \[[@B11][@B12][@B13][@B17][@B18][@B19][@B20]\], so random-effect model was used. The association between PIH and iSUA were seen in all meta-analyses. The reported ORs in the 7 individual studies ranged from 0.72 to 5.25 and OR was 1.62 (95% CI, 1.00 to 2.63; *P*=0.05), indicating that the incidence of PIH in fetuses with iSUA was significantly higher than that in fetuses with TVC and iSUA was associated with the occurrence of PIH.

5. NICU admission
-----------------

When we pooled the data from the 2 case-control studies and 4 cohort studies, we found a statistically significant association between iSUA and admission to the NICU (OR, 2.06; 95% confidence interval \[CI\], 1.33 to 3.19; *P*=0.001) ([Fig. 5](#F5){ref-type="fig"}) \[[@B12][@B13][@B14][@B16][@B18][@B20]\].

6. Perinatal mortality
----------------------

For perinatal mortality, estimates were reported from 5 retrospective cohort studies and one case-control study with 1,176 iSUA cases. No heterogeneity was found (chi^2^=2.40, *P*=0.66, I^2^=0%), we chose fixed-effect model to do the meta-analysis. This meta-analysis showed that perinatal mortality is significantly associated with iSUA (OR, 2.29; 95% CI, 1.32 to 3.98; *P*=0.003) ([Fig. 6](#F6){ref-type="fig"}) \[[@B13][@B14][@B15][@B16][@B17][@B18]\].

Discussion
==========

This study performed a meta-analysis of 11 studies that considered the relationship between prenatally diagnosed iSUA and perinatal outcomes, including SGA, preterm birth, PIH, and perinatal mortality. There has been controversy regarding the association between iSUA and fetal growth. Tulek et al. \[[@B11]\] analyzed birth weight and found that SGA was three-fold as likely in pregnancies with iSUA compared to pregnancies with TVC. Other recent studies also reported similar results \[[@B13][@B17][@B18][@B19][@B20]\]. However, Bombrys et al. \[[@B14]\] found that iSUA was not associated with a higher rate of SGA in comparison with newborns with TVC (13.7% vs. 13.9%, *P*=0.93). Horton et al. \[[@B16]\] reported that even though the ponderal index, which is a more accurate measure of neonatal slenderness, was significantly lower in neonates with iSUA compared with TVC neonates (24.2±1.1 vs. 26.1±1.3 g/cm^3^, *P*=0.001), there was no significant difference in rates of SGA (17.6% vs. 8.8%, *P*=0.06).

The association between preterm birth and iSUA is also controversial. Some studies have shown a higher risk of preterm birth in cases with iSUA \[[@B13][@B20]\] and others have demonstrated no association \[[@B11]\]. Hua et al. \[[@B17]\] did not find a higher rate of preterm birth when comparing newborns with iSUA with those with normal umbilical cord. Murphy-Kaulbeck et al. \[[@B22]\] demonstrated that rates of prematurity were significantly higher for less than 37 weeks of gestation (OR, 2.48; 95% CI, 1.91 to 3.23).

The relationship between iSUA and perinatal mortality also remains controversial. In the study conducted by Bombrys et al. \[[@B14]\], the finding of iSUA was not associated with increased perinatal morbidity or mortality. Burshtein et al. \[[@B23]\] reported iSUA as an independent risk factor for perinatal mortality (OR, 7.78; 95% CI, 4.68 to 12.95).

It has been hypothesized that the high incidence of SGA, NICU admission, and perinatal mortality in fetuses with iSUA may occur secondary to a relatively high prevalence of preterm birth \[[@B11][@B12][@B13][@B14][@B15]\]. But it is not clear why the incidence of gestational hypertension and preeclampsia is higher for fetuses that have a single umbilical artery but appear to be structurally normal. One hypothesis is that fetuses with single umbilical arteries are at greater risk of anomalous cord development, as part of a wider pathological process affecting the placenta and perfusion rather than inadequate fetoplacental blood flow through the remaining umbilical artery \[[@B15]\]. Haugen et al. \[[@B24]\] reported further evidence in support of this hypothesis by showing that SUA displayed markedly higher outflow levels of prostacyclin, endothelium-derived relaxing factor. Moreover, the vasoactive intestinal peptide that induces dose-dependent relaxation is able to increase the prostacyclin formation in the two umbilical arteries rather than in the SUA \[[@B24][@B25][@B26]\].

The first systematic review and meta-analysis on the association between the presence of an iSUA and perinatal outcomes was published in 2013, and reported that there was no statistically significant difference in perinatal mortality between fetuses with an iSUA and TVC \[[@B27]\]. As stated in that meta-analysis, this non-significant result might be due to the limited sample size; the study included only 7 eligible papers covering 928 cases with iSUA. In contrast, our meta-analysis included 11 eligible studies covering 1,731 pregnancies with iSUA.

In our meta-analysis, there were statistically significant differences in the incidence of SGA, preterm birth, PIH, and perinatal mortality between iSUA and TVC fetuses, implying that the incidence of these complications was correlated with iSUA, and that iSUA may increase the risk of these complications.

This meta-analysis provides the best currently available evidence of an association between iSUA and perinatal outcomes. This review provides much needed information about iSUA and perinatal outcomes and will help in the counselling of women with a fetus with iSUA. To our knowledge, this review is the most comprehensive meta-analysis evaluating the association of iSUA and perinatal outcomes. We performed an extensive literature search without language restrictions, thereby increasing the likelihood of retrieving all relevant studies.

This review has several limitations. The main weakness of these studies was the retrospective design and the fact that most of the outcomes were explored by a limited number of studies, despite our efforts to identify all relevant literature. Although the quality assessment of the studies was generally high, the heterogeneity was significant for all outcomes analyzed. Since large or extreme heterogeneity may lead to a misleading conclusion, the degree of heterogeneity is one of the main concerns in meta-analysis. In this study, significant heterogeneity was present in the overall analysis.

Our meta-analysis has provided a systematic review of the association between the presence of an iSUA and various perinatal outcomes. Our results suggest that iSUA is associated with a significant increase in adverse perinatal outcomes such as SGA, preterm birth, PIH, admission to the NICU, and perinatal mortality.
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###### Characteristics of studies in the meta-analysis

![](ogs-60-266-i001)

  Author                       Year   Country        Study design           Follow up    SUA   TVC
  ---------------------------- ------ -------------- ---------------------- ------------ ----- --------
  Gornall \[[@B15]\]           2003   UK             Cohort retrospective   1995--2001   107   214
  Predanic \[[@B21]\]          2005   USA            Case control           1999--2004   84    84
  Bombrys \[[@B14]\]           2008   USA            Cohort retrospective   2000--2006   255   289
  Horton \[[@B16]\]            2010   USA            Case control           2000--2008   68    68
  Hua \[[@B17]\]               2010   USA            Cohort retrospective   1990--2007   392   63,655
  Khalil \[[@B18]\]            2013   Saudi Arabia   Cohort retrospective   2004--2012   159   35,026
  Mailath-Pokorny \[[@B19]\]   2015   Austria        Cohort retrospective   2004--2011   136   500
  Ashwal \[[@B12]\]            2014   Israel         Case control           2008--2012   91    182
  Battarbee \[[@B13]\]         2015   USA            Cohort retrospective   2007--2014   219   219
  Naveiro-Fuentes \[[@B20]\]   2016   Spain          Cohort retrospective   2007--2014   127   27,752
  Tülek \[[@B11]\]             2015   Turkey         Cohort retrospective   2006--2013   93    100

Only first author of each study is given.

SUA, single umbilical artery; TVC, three vessel cord.
